Literature DB >> 6109753

Effects of fetal treatment with methylazoxymethanol acetate at various gestational dates on the neurochemistry of the adult neocortex of the rat.

M V Johnston, A B Carman, J T Coyle.   

Abstract

The effects of gestational date (13, 14, 15, and 17 days) or administration of methylazoxymethanol acetate (20 mg/kg) on the cortical synaptic chemistry and morphology of the rat has been examined in adult offspring. Treatment at 13 days of gestation (DG) resulted in cortical hypoplasia that affected primarily the deep layers whereas treatment at 14 and 15 days gestation caused a severe hypoplasia of cortical neurons above layer V and a 66 to 77% reduction in cortical mass. The 17-DG treatment caused only a 20% reduction in cortical weight with effects apparent only in the superficial layers. At no treatment date did the specific activity of glutamate decarboxylase differ significantly from control. In contrast, presynaptic markers for noradrenergic (tyrosine hydroxylase and norepinephrine) and for serotonergic (serotonin) terminals were increased in concentration in direct proportion to the degree of cortical hypoplasia. The specific activity of choline acetyltransferase was significantly increased at all treatment dates but total activity per cortical slab was significantly reduced on treatment days 13-15.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6109753     DOI: 10.1111/j.1471-4159.1981.tb02386.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  The distribution of serotonergic nerves in microencephalic rats treated prenatally with methylazoxymethanol.

Authors:  Y Kodama; R Nonaka; Y Hagino; M Watanabe
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

2.  Changes in postnatal norepinephrine alter alpha-2 adrenergic receptor development.

Authors:  J D Sanders; H K Happe; D B Bylund; L C Murrin
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

3.  Effect of prenatal treatment with methylazoxymethanol on carbachol-, norepinephrine- and glutamate-stimulated phosphoinositide metabolism in the neonatal, young, and adult offspring.

Authors:  W Balduini; G Lombardelli; G Peruzzi; F Cattabeni
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

Review 4.  Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia.

Authors:  Susan F Sonnenschein; Anthony A Grace
Journal:  Neuropharmacology       Date:  2019-05-08       Impact factor: 5.250

5.  Cholinergic hyperinnervation in the cerebral cortex of microencephalic rats does not result in muscarinic receptor down-regulation or in alteration of receptor-stimulated phosphoinositide metabolism.

Authors:  W Balduini; G Lombardelli; G Peruzzi; F Cattabeni
Journal:  Neurochem Res       Date:  1992-08       Impact factor: 3.996

Review 6.  Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia.

Authors:  Susan F Sonnenschein; Felipe V Gomes; Anthony A Grace
Journal:  Front Psychiatry       Date:  2020-06-30       Impact factor: 4.157

Review 7.  Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis.

Authors:  Susan F Sonnenschein; A Grace
Journal:  Expert Opin Ther Targets       Date:  2020-11-26       Impact factor: 6.902

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.